SELLAS Life Sciences Group

SLSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.234 B

$12.01 +2.65%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$26.9M

Loss-making

Shares outstanding

179,582,574

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#103Mineralys TherapeuticsMLYS$2.26B
#104Harmony BiosciencesHRMY$2.24B
#105SELLAS Life Sciences GroupSLS$2.23B
#106BiohavenBHVN$2.21B
#107Braveheart BioBRVE$2.20B

Where these numbers come from

Share counts and financials for SELLAS Life Sciences Group are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.